Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net (loss) income	$ (408,133)	$ 287,967
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	45,970	42,235
Change in inventory reserve		(13,240)
Stock compensation expense	81,708	188,237
Loss on deconsolidation of subsidiaries		75,138
Change in fair value of EIB loan guaranty		46,584
Gain on impairment adjustment		(2,079,575)
Changes in operating assets and liabilities:
Accounts receivable	(4,838)	65,348
Inventory		13,240
Prepaid expenses and other current assets	217,677	97,622
Intangible assets	(12,500)
Accounts payable	66,441	80,426
Accrued compensation and benefits	(43,197)	(79,773)
Accrued liabilities	(10,535)	243,110
Short-term insurance financing	(90,278)
Operating lease liabilities	(40,187)	(34,014)
Deferred revenue		(17,355)
Net cash used in operating activities	(197,872)	(1,084,050)
Cash flows from investing activities:
Purchases of property and equipment
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issuance of preferred stock, net of issuance costs		200,000
Proceeds from short term insurance financing	300,926
Payments on short term insurance financing	(300,926)
Payments on finance lease obligations		(280)
Net cash provided by financing activities		199,720
Effects of exchange rates on cash
Net decrease in cash, cash equivalents and restricted cash	(197,872)	(884,330)
Cash and cash equivalents and restricted cash at beginning of period	1,612,915	1,454,085
Cash and cash equivalents and restricted cash at end of period	1,415,043	569,755
Supplemental disclosure of cash flow information
Cash paid for interest	$ 3,238